Annual Revenue
$258.00 M
+$141.00 M+120.51%
December 31, 2024
Summary
- As of March 13, 2025, RCUS annual revenue is $258.00 million, with the most recent change of +$141.00 million (+120.51%) on December 31, 2024.
- During the last 3 years, RCUS annual revenue has fallen by -$125.00 million (-32.64%).
- RCUS annual revenue is now -32.64% below its all-time high of $383.00 million, reached on December 31, 2021.
Performance
RCUS Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$26.00 M
-$22.00 M-45.83%
December 31, 2024
Summary
- As of March 13, 2025, RCUS quarterly revenue is $26.00 million, with the most recent change of -$22.00 million (-45.83%) on December 31, 2024.
- Over the past year, RCUS quarterly revenue has dropped by -$5.00 million (-16.13%).
- RCUS quarterly revenue is now -92.67% below its all-time high of $354.62 million, reached on December 31, 2021.
Performance
RCUS Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$258.00 M
-$5.00 M-1.90%
December 31, 2024
Summary
- As of March 13, 2025, RCUS TTM revenue is $258.00 million, with the most recent change of -$5.00 million (-1.90%) on December 31, 2024.
- Over the past year, RCUS TTM revenue has increased by +$141.00 million (+120.51%).
- RCUS TTM revenue is now -40.36% below its all-time high of $432.62 million, reached on September 30, 2022.
Performance
RCUS TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
RCUS Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +120.5% | -16.1% | +120.5% |
| 3 y3 years | -32.6% | -92.7% | -32.6% |
| 5 y5 years | +1620.0% | +166.7% | +1620.0% |
RCUS Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -32.6% | +130.4% | -92.7% | +44.4% | -40.4% | +130.4% |
| 5 y | 5-year | -32.6% | +1620.0% | -92.7% | +1385.7% | -40.4% | +1620.0% |
| alltime | all time | -32.6% | >+9999.0% | -92.7% | >+9999.0% | -40.4% | >+9999.0% |
Arcus Biosciences Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $258.00 M(+120.5%) | $26.00 M(-45.8%) | $258.00 M(-1.9%) |
| Sep 2024 | - | $48.00 M(+23.1%) | $263.00 M(+6.5%) |
| Jun 2024 | - | $39.00 M(-73.1%) | $247.00 M(+4.2%) |
| Mar 2024 | - | $145.00 M(+367.7%) | $237.00 M(+102.6%) |
| Dec 2023 | $117.00 M(+4.5%) | $31.00 M(-3.1%) | $117.00 M(-2.5%) |
| Sep 2023 | - | $32.00 M(+10.3%) | $120.00 M(-0.8%) |
| Jun 2023 | - | $29.00 M(+16.0%) | $121.00 M(+1.7%) |
| Mar 2023 | - | $25.00 M(-26.5%) | $119.00 M(+6.3%) |
| Dec 2022 | $112.00 M(-70.8%) | $34.00 M(+3.0%) | $112.00 M(-74.1%) |
| Sep 2022 | - | $33.00 M(+22.2%) | $432.62 M(+5.8%) |
| Jun 2022 | - | $27.00 M(+50.0%) | $409.08 M(+4.5%) |
| Mar 2022 | - | $18.00 M(-94.9%) | $391.54 M(+2.2%) |
| Dec 2021 | $383.00 M | $354.62 M(+3648.2%) | $383.00 M(+898.6%) |
| Sep 2021 | - | $9.46 M(0.0%) | $38.35 M(-58.9%) |
| Jun 2021 | - | $9.46 M(0.0%) | $93.42 M(+9.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $9.46 M(-5.1%) | $85.71 M(+9.9%) |
| Dec 2020 | $78.00 M(+420.0%) | $9.97 M(-84.5%) | $78.00 M(+0.3%) |
| Sep 2020 | - | $64.53 M(+3587.4%) | $77.78 M(+418.5%) |
| Jun 2020 | - | $1.75 M(0.0%) | $15.00 M(0.0%) |
| Mar 2020 | - | $1.75 M(-82.1%) | $15.00 M(0.0%) |
| Dec 2019 | $15.00 M(+79.6%) | $9.75 M(+457.1%) | $15.00 M(+120.2%) |
| Sep 2019 | - | $1.75 M(0.0%) | $6.81 M(-27.2%) |
| Jun 2019 | - | $1.75 M(0.0%) | $9.35 M(+5.6%) |
| Mar 2019 | - | $1.75 M(+12.0%) | $8.85 M(+6.0%) |
| Dec 2018 | $8.35 M(+491.2%) | $1.56 M(-63.6%) | $8.35 M(+3.9%) |
| Sep 2018 | - | $4.29 M(+243.3%) | $8.04 M(+105.5%) |
| Jun 2018 | - | $1.25 M(0.0%) | $3.91 M(+46.9%) |
| Mar 2018 | - | $1.25 M(0.0%) | $2.66 M(+88.5%) |
| Dec 2017 | $1.41 M | $1.25 M(+666.9%) | $1.41 M(+766.9%) |
| Sep 2017 | - | $163.00 K | $163.00 K |
FAQ
- What is Arcus Biosciences annual revenue?
- What is the all time high annual revenue for Arcus Biosciences?
- What is Arcus Biosciences annual revenue year-on-year change?
- What is Arcus Biosciences quarterly revenue?
- What is the all time high quarterly revenue for Arcus Biosciences?
- What is Arcus Biosciences quarterly revenue year-on-year change?
- What is Arcus Biosciences TTM revenue?
- What is the all time high TTM revenue for Arcus Biosciences?
- What is Arcus Biosciences TTM revenue year-on-year change?
What is Arcus Biosciences annual revenue?
The current annual revenue of RCUS is $258.00 M
What is the all time high annual revenue for Arcus Biosciences?
Arcus Biosciences all-time high annual revenue is $383.00 M
What is Arcus Biosciences annual revenue year-on-year change?
Over the past year, RCUS annual revenue has changed by +$141.00 M (+120.51%)
What is Arcus Biosciences quarterly revenue?
The current quarterly revenue of RCUS is $26.00 M
What is the all time high quarterly revenue for Arcus Biosciences?
Arcus Biosciences all-time high quarterly revenue is $354.62 M
What is Arcus Biosciences quarterly revenue year-on-year change?
Over the past year, RCUS quarterly revenue has changed by -$5.00 M (-16.13%)
What is Arcus Biosciences TTM revenue?
The current TTM revenue of RCUS is $258.00 M
What is the all time high TTM revenue for Arcus Biosciences?
Arcus Biosciences all-time high TTM revenue is $432.62 M
What is Arcus Biosciences TTM revenue year-on-year change?
Over the past year, RCUS TTM revenue has changed by +$141.00 M (+120.51%)